Axitinib

1.Axitinib is an oral targeted therapy drug mainly used to treat renal cell carcinoma (kidney cancer).
2. Axitinib belongs to a class of drugs called tyrosine kinase inhibitors, which prevent the growth and spread of tumor cells by inhibiting specific tyrosine kinases in the process of tumor angiogenesis.
3. The main function of Axitinib is to inhibit the angiogenesis of tumor cells, thereby reducing the blood supply to the tumor and causing tumor cell death.
4.Axitinib is commonly used to treat advanced renal cell carcinoma, especially in patients who have failed to respond to traditional treatments.

Axitinib is widely used in the pharmaceutical field.